Search results
Results from the WOW.Com Content Network
The amount of peer-reviewed research on psychedelics has accordingly been limited due to the difficulty of getting approval from institutional review boards. [72] Furthermore, scientific studies on entheogens present some significant challenges to researchers, including philosophical questions relating to ontology, epistemology and objectivity ...
Sep. 13—Staff report A free continuing education training will soon be available virtually sponsored by the Area Agency on Aging District 7 (AAA7). "Opioid Use Disorders and Older Adults ...
The Harvard Psilocybin Project was a series of experiments in psychology conducted by Timothy Leary and Richard Alpert.The founding board of the project consisted of Leary, Aldous Huxley, David McClelland (Leary's and Alpert's superior at Harvard University), [21] Frank Barron, Ralph Metzner, and two graduate students who were working on a project with mescaline.
Psychedelic: Mazatec [12] Harmal (espand, Syrian rue) Peganum harmala: Seed: Harmaline and other harmala alkaloids: Psychedelic: Iran and the Middle East. Hawaiian baby woodrose: Argyreia nervosa: Seed: 0.325% ergoline derivatives of dry weight. [13] Psychedelic: Huna shamans used them according to various oral histories. [14] Henbane ...
Carl Ruck is best known for his work along with other scholars in mythology and religion on the sacred role of entheogens, or psychoactive plants that induce an altered state of consciousness, as used in religious or shamanistic rituals.
The International Center for Ethnobotanical Education, Research & Service (ICEERS) was founded on May 20, 2009, by Benjamin De Loenen (director of the 2014 documentary Ibogaine - Rite of Passage) as a philanthropic, tax-exempt non-profit organization (charity) dedicated to the integration of ayahuasca, iboga and other traditional plants as therapeutic tools in modern society, and the ...
Terence McKenna advocated the exploration of altered states of mind via the ingestion of naturally occurring psychedelic substances; [5] [32] [43] for example, and in particular, as facilitated by the ingestion of high doses of psychedelic mushrooms, [26] [55] ayahuasca, and DMT, [6] which he believed was the apotheosis of the psychedelic ...
The founding of MAPS was a primary step toward the future envisioning of what Doblin has called a "nonprofit psychedelic-pharmaceutical company." [5] Chartered in 1986, MAPS has since contributed over 12 million dollars towards the scientific study of psychedelics and cannabis in therapeutic applications. [6] [7]